John McCabe Email

CFO & COO . DEM Biopharma

Cambridge, MA

Location

LinkedIn

Current Roles

Employees:
45
Revenue:
$3.5M
About
DEM Bio is pioneering the next generation of immunotherapeutics that unleash macrophages and immune phagocytes to eliminate tumors by targeting ‘Don’t eat me’ (DEM) and ‘Eat me’ (EM) signals on cancer cells and macrophages. Founded by Longwood Fund and is supported by a syndicate of biotech investors and headquartered in Boston, MA.
DEM Biopharma Address
1 Kendall Sq
Cambridge, MA
DEM Biopharma Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.